Horm Metab Res 2009; 41(6): 426-429
DOI: 10.1055/s-0029-1214414
Humans, Clinical

© Georg Thieme Verlag KG Stuttgart · New York

CTLA-4 CT60 Polymorphism in Thyroid and Polyglandular Autoimmunity

G. Dultz 1 , N. Matheis 1 , M. Dittmar 2 , K. Bender 3 , G. J. Kahaly 1
  • 1Department of Medicine I, Gutenberg University, Mainz, Germany
  • 2Department of Human Biology, Christian-Albrechts-University, Kiel, Germany
  • 3Institute of Legal Medicine, Gutenberg University, Mainz, Germany
Further Information

Publication History

received 18.12.2008

accepted 11.02.2009

Publication Date:
06 April 2009 (online)

Abstract

Autoimmune thyroid diseases (AITDs) frequently occur together with other endocrine autoimmune conditions, denominated as polyglandular autoimmunity (PGA). The cytotoxic T-lymphocyte antigen 4 (CTLA-4) gene was recently associated with AITD and PGA, and the CTLA-4 protein is a strong inhibitor of T-cells. The tumor necrosis factor alpha (TNF-α) is a proinflammatory cytokine. This study aimed to analyze the association of the CTLA-4 CT60 and TNF-α -863 polymorphisms with PGA. Homogeneous groups of 70 patients with AITD, 70 with type 1 diabetes (T1D), 70 with both AITD and T1D (PGA), and 100 healthy controls were genotyped for the CTLA-4 CT60 and TNF-α -863 polymorphisms by minisequencing on an ABI PRISM-3100 genetic analyzer. The CT60 G/G genotype was significantly more common in patients with PGA than in healthy controls (48.6% vs. 32.0%, OR=2.01, 95% CI=1.07–3.77, p=0.038). The CT60 allele frequencies differed as well between PGA patients and controls, with the predisposing G allele being increased in PGA (OR=1.63, 95% CI=1.03–2.55, p=0.042). Patients with PGA did not differ from those with AITD (p=0.602) or T1D (p=0.362). For TNF-α -863, carriers of the minor A allele occurred more frequently in the T1D group than in controls (47.1% vs. 33%, OR=1.81, 95% CI=0.97–3.39, p=0.079), but no differences in allele or genotype distribution were noted between PGA patients and controls (p=0.886 and 0.389, respectively). In conclusion the CTLA-4 CT60 polymorphism is associated with PGA.

References

  • 1 Dittmar M, Kahaly GJ. Immunoregulatory and susceptibility genes in thyroid and polyglandular autoimmunity.  Thyroid. 2005;  15 239-250
  • 2 Jacobson EM, Tomer Y. The genetic basis of thyroid autoimmunity.  Thyroid. 2007;  17 949-961
  • 3 Dittmar M, Kahaly GJ. Polyglandular autoimmune syndromes: Immunogenetics and long-term follow-up.  J Clin Endocrinol Metab. 2003;  88 2983-2992
  • 4 Eisenbarth GS, Gottlieb PA. Autoimmune polyendocrine syndromes.  New Engl J Med. 2004;  350 2068-2079
  • 5 Dittmar M, Ide M, Wurm M, Kahaly GJ. Early onset of polyglandular failure is associated with HLA-DRB1*03.  Eur J Endocrinol. 2008;  159 55-60
  • 6 Dultz G, Dittmar M, Matheis N, Röhrig B, Bender K, Kahaly GJ. The protein tyrosin phosphatase non-receptor type 22 C1858 T polymorphism is a joint susceptibility locus for immunthyroiditis and autoimmune diabetes.  Thyroid. 2009;  19 143-148
  • 7 Huber A, Menconi F, Corathers S, Jacobson EM, Tomer Y. Joint genetic susceptibility to type 1 diabetes and autoimmune thyroiditis: from epidemiology to mechanisms.  Endocr Rev. 2008;  29 697-725
  • 8 Ueda H, Howson JM, Esposito L, Heward J, Snook H, Chamberlain G, Rainbow DB, Hunter KM, Smith AN, Di Genova G, Herr MH, Dahlman I, Payne F, Smyth D, Lowe C, Twells RC, Howlett S, Healy B, Nutland S, Rance HE, Everett V, Smink LJ, Lam AC, Cordell HJ, Walker NM, Bordin C, Hulme J, Motzo C, Cucca F, Hess JF, Metzker ML, Rogers J, Gregory S, Allahabadia A, Nithiyananthan R, Tuomilehto-Wolf E, Tuomilehto J, Bingley P, Gillespie KM, Undlien DE, Rønningen KS, Guja C, Ionescu-Tîrgovi°te C, Savage DA, Maxwell AP, Carson DJ, Patterson CC, Franklyn JA, Clayton DG, Peterson LB, Wicker LS, Todd JA, Gough SC. Association of the T-cell regulatory gene CTLA4 with susceptibility to autoimmune disease.  Nature. 2003;  423 506-511
  • 9 Liu C, Papewalis C, Domberg J, Scherbaum WA, Schott M. Chemokines and autoimmune thyroid diseases.  Horm Metab Res. 2008;  40 361-368
  • 10 Domber J, Liu C, Papewalis C, Pfleger C, Xu K, Willenberg HS, Hermsen D, Scherbaum WA, Schloot NC, Schott M. Circulating chemokines in patients with autoimmune thyroid diseases.  Horm Metab Res. 2008;  40 416-421
  • 11 Weetman AP, Rees AJ. Synergistic effects of recombinant tumour necrosis factor and interferon-gamma on rat thyroid cell growth and Ia antigen expression.  Immunology. 1988;  63 285-289
  • 12 Deuss U, Buscema M, Schumacher H, Winkelmann W. In vitro effects of tumor necrosis factor-alpha on human thyroid follicular cells.  Acta Endocrinol (Copenh). 1992;  127 220-225
  • 13 Kamizono S, Hiromatsu Y, Seki N, Bednarczuk T, Matsumoto H, Kimura A, Itoh K. A polymorphism of the 5′ flanking region of tumour necrosis factor alpha gene is associated with thyroid-associated ophthalmopathy in Japanese.  Clin Endocrinol (Oxf). 2000;  52 759-764
  • 14 Li N, Zhou Z, Liu X, Liu Y, Zhang J, Du L, Wei M, Chen X. Association of tumour necrosis factor alpha (TNF-alpha) polymorphisms with Graves’ disease: A meta-analysis.  Clin Biochem. 2008;  41 881-886
  • 15 Ostrov DA, Shi W, Schwartz JC, Almo SC, Nathenson SG. Structure of murine CTLA-4 and its role in modulating T cell responsiveness.  Science. 2000;  290 816-819
  • 16 Krummel MF, Sullivan TJ, Allison JP. Superantigen responses and costimulation: CD28 and CTLA-4 have opposing effects on T cell expansion in vitro and in vivo.  Int Immunol. 1996;  8 519-523
  • 17 Walunas TL, Lenschow DJ, Bakker CY, Linsley PS, Freeman GJ, Green JM, Thompson CB, Bluestone JA. CTLA-4 can function as a negative regulator of T cell activation.  Immunity. 1994;  1 405-413
  • 18 Kawoura FK, Akamizu T, Awata T, Ban Y, Chistiakov DA, Frydecka I, Ghaderi A, Gough SC, Hiromatsu Y, Ploski R, Wang PW, Ban Y, Bednarczuk T, Chistiakova EI, Chojm M, Heward JM, Hiratani H, Juo SH, Karabon L, Katayama S, Kurihara S, Liu RT, Miyake I, Omrani GH, Pawlak E, Taniyama M, Tozaki T, Ioannidis JP. Cytotoxic T-lymphocyte associated antigen 4 gene polymorphisms and autoimmune thyroid disease: a meta-analysis.  J Clin Endocrinol Metab. 2007;  92 3162-3170
  • 19 Kordonouri O, Klinghammer A, Lang EB, Grüters-Kieslich A, Grabert M, Holl RW. Thyroid autoimmunity in children and adolescents with type 1 diabetes: a multicenter survey.  Diabetes Care. 2002;  25 1346-1350
  • 20 Bright GM, Blizzard RM, Kaiser DL, Clarke WL. Organ-specific autoantibodies in children with common endocrine diseases.  J Pediatr. 1982;  100 8-14
  • 21 Higuchi T, Seki N, Kamizono S, Yamada A, Kimura A, Kato H, Itoh K. Polymorphism of the 5′-flanking region of the human tumor necrosis factor (TNF)-alpha gene in Japanese.  Tissue Antigens. 1998;  51 605-612

Correspondence

Prof. Dr. G. J. Kahaly

Department of Medicine I

Gutenberg University Hospital

Langenbeckstr. 1

55131 Mainz

Germany

Phone: +49/6131/17 37 68

Fax: +49/6131/17 34 60

Email: gkahaly@uni-mainz.de

    >